HOSPITAL SERIES
Sun Yat-sen University Cancer Center: Specialist Cancer Care in Guangzhou
Sun Yat-sen University Cancer Center (SYSUCC) in Guangzhou brings cancer treatment, research and medical education into one specialist institution. Its disease-focused teams span surgery, medical oncology and radiotherapy, with gastrointestinal and nasopharyngeal cancers among the fields covered in this article.

A Cancer Center Established in 1964
SYSUCC was established in 1964 and is affiliated with Sun Yat-sen University. It is a specialist cancer institution, bringing together patient care, prevention, research and the training of oncology professionals.
Its May 2024 introduction reported more than 1.84 million outpatient visits and 45,492 surgeries in 2023. These are hospital-reported historical figures, but they convey the scale of a center where disease-specific teams see a substantial range of cancer cases.
Sources: [1]
Disease-Specific Teams Across Cancer Care
The center’s department directory includes medical oncology, radiation oncology, breast oncology, colorectal and gastric surgery, head and neck surgery, pathology and molecular diagnosis. Each contributes a different part of cancer assessment and treatment.
This structure is valuable when a question crosses specialties—for example, when a proposed drug treatment depends on pathology findings or a surgical assessment needs to be considered alongside radiotherapy. The specialist question and records determine which disciplines should participate in a review.
Sources: [2]
Gastrointestinal Oncology and Drug Research
SYSUCC’s medical oncology work includes gastrointestinal cancers, which affect the digestive system. Its research addresses areas such as cancer drug resistance, treatment response and the biology of metastasis.
A 2023 Cancer Cell study involving the center’s Medical Oncology team examined classification of advanced esophageal squamous cell carcinoma in patients receiving chemotherapy plus PD-1 blockade. The work illustrates how clinical observations and tumor biology can inform research into treatment response.
Nasopharyngeal Cancer and Radiation Oncology
The center has a dedicated nasopharyngeal cancer program and a radiation oncology team that includes clinical specialists, medical physicists and treatment staff. Nasopharyngeal cancer develops in the upper part of the throat behind the nose.
Its researchers have contributed to international studies of treatment sequencing. A 2019 New England Journal of Medicine phase 3 trial from this research program examined chemotherapy given before chemoradiotherapy. The separate feature on Ma Jun takes a closer look at the specialist and the research behind this field.
Featured Specialist: Xu Ruihua

Xu Ruihua, whose English publications also use Rui-Hua Xu, is a professor of Medical Oncology. His official SYSUCC biography identifies gastrointestinal cancers as his main clinical interest, alongside early detection, metastasis and drug resistance research.
The 2023 Cancer Cell esophageal cancer study lists Xu with a SYSUCC Medical Oncology affiliation. His clinical focus and published work illustrate the center’s combination of digestive-system cancer care with research into why treatments work differently for different tumors.
International Patient Information and Written Reviews
SYSUCC publishes an international patient guide covering medical documents and registration requirements. The published pathway includes Chinese-language medical records. Overseas patients therefore need to clarify translation and document formats as part of arranging care.
China Heal Plus focuses on written specialist second opinions. We confirm whether the provider can accept the request, which specialist will review it, which records are required and what the report will contain before agreeing the service scope. Public doctor biographies are background information, rather than confirmation of a partnership or appointment.
Sources: [7]
Sources and data notes
- SYSUCC: institutional introduction
Official introduction updated May 2024. Rechecked 8 October 2026. Activity figures relate to 2023; campus plans are not presented as completed facilities.
- SYSUCC: official medical department directory
Primary institutional department list; specialty presence does not establish overseas remote acceptance. Rechecked 8 October 2026.
- SYSUCC: Rui-Hua Xu official expert biography
Official clinical interests and institutional biography rechecked 8 October 2026. The older itemid=154 page now contains little substantive biography; this fuller current source replaces it. Appointment availability is separate.
- PubMed: esophageal cancer classification study, PMID 37059106
Cancer Cell, 2023. Author and Medical Oncology affiliation rechecked through official NCBI EFetch on 8 October 2026; research involvement is not a personal treatment recommendation. Rechecked 8 October 2026.
- SYSUCC: Radiation Oncology department and specialists
Official department description read this round; undated scale/equipment figures are not used as current counts. Rechecked 8 October 2026.
- PubMed: nasopharyngeal cancer phase 3 trial, PMID 31150573
New England Journal of Medicine, 2019. Trial design, Jun Ma authorship and SYSUCC Radiation Oncology affiliation checked; no current appointment implication. Rechecked 8 October 2026.
- SYSUCC: international patient information
Published visit and document requirements. This guide is not evidence that every overseas remote request will be accepted. Rechecked 8 October 2026.
Published by China Heal Plus. General information, not an individual medical assessment. Inclusion of a hospital or physician does not imply a partnership or endorsement of our service.